The focus of this seminar is on increasing the success of Biotech. Participation is free of charge.
When and where:
September 15th, 2015
16:00 – 17:30
Hotel Vier Jahreszeiten Starnberg
Münchner Straße 17
82319 Starnberg, Germany
Agenda:
- 16:00 – 16:15 Opening, Izaak den Daas, PhD, Principal Scientist QPS
- 16:15 – 16:30 Problems and Challenges for the Biotech Industry, Edwin van Vulpen, QPS
- 16:30 – 17:00 Investments in Biotech: Considerations for Venture Capitalists, Dr. Holger Reithinger, Partner at FORBION
- 17:00 – 17:30 The New EU Clinical Trial Directive, Patricia Baede, MSc, Regulatory Expert at QPS
- 17:30 – 21:00 Seminar dinner
Contact us today if you would like to join the QPS Continuing Education Conference in Germany.
Contact:
Edwin van Vulpen, Senior Director Business Development Early Phase Clinical
edwin.van.vulpen@www.qps.com
Mobile: +31610000195
Learn more about QPS’ clinical development services
